Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac diethylamine phonophoresis for cervical spondylosis
IRCT20240713062426N1Phase 3Completed
- Sponsor
- The University of Lahore
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of diclofenac diethylammonium in cervical osteoarthritis (2 arms), sponsored by The University of Lahore. Primary endpoints: Pain, Cervical disability and 2 more. Started Feb 2024; status: completed.
02
Drugs
diclofenac diethylammonium
03
Conditions
cervical osteoarthritis
Beyond the preview
Go deeper on IRCT20240713062426N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240713062426N1.